ClinicalTrials.Veeva

Menu

Expert Consensus on Photoprotection Practices: A Delphi Study

V

Venus Research Center

Status

Invitation-only

Conditions

Sunscreen
Sun Exposure
Sun Damaged Skin
Photoprotection
Sunscreen Agents

Study type

Observational

Funder types

Other

Identifiers

NCT07296588
Photoprotection-VRC

Details and patient eligibility

About

This study is a Delphi-based expert consensus project aimed at developing evidence-informed recommendations for photoprotection practices across various populations, including general, at-risk, and special groups (e.g., children, pregnant women, patients with photodermatoses). Despite extensive evidence on the importance of sun protection, there is variability in clinical advice regarding sunscreen selection, application frequency, SPF requirements, adjunctive protective measures, and patient counseling.

Full description

This study is a non-interventional, methodological Delphi consensus project designed to develop standardized recommendations for photoprotection practices. Photoprotection encompasses strategies to minimize ultraviolet (UV)-related skin damage, including sunscreen use, clothing, behavioral measures, and patient education. Despite broad awareness campaigns, inconsistencies exist regarding SPF selection, application methods, timing, reapplication frequency, and the use of additional protective measures.

A steering committee of dermatologists and photoprotection experts will conduct a literature review and draft initial statements addressing key domains:

Sunscreen use: SPF level, spectrum coverage (UVA/UVB), formulation (chemical vs. physical), water resistance.

Application guidelines: Amount, timing before sun exposure, reapplication frequency, body coverage.

Adjunctive measures: Protective clothing, hats, sunglasses, shade-seeking behavior.

Special populations: Children, pregnant women, outdoor workers, patients with photosensitive dermatoses.

Behavioral counseling: Education strategies, adherence promotion, and misconceptions.

Integration with skin care and aesthetic practices.

A panel of experts in dermatology, photobiology, and related fields will participate in multiple Delphi rounds. Panelists will rate agreement with each statement using a Likert scale. Anonymized feedback will be provided after each round, and statements not reaching a predefined consensus threshold (e.g., ≥70-80%) will be revised and re-evaluated in subsequent rounds.

The final output will consist of consensus-based recommendations reflecting practical, safe, and evidence-informed photoprotection practices. Areas of disagreement or uncertainty will also be highlighted, identifying research gaps and priorities for future studies.

Enrollment

15 estimated patients

Sex

All

Ages

25+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Board-certified dermatologists, photobiologists, or clinicians/researchers with ≥5 years of relevant experience.

Regular involvement in advising on photoprotection, skin cancer prevention, or UV-related dermatology.

Engagement in research, guideline development, teaching, or professional society activities related to dermatology, photobiology, or public health.

Willingness and availability to participate in all Delphi rounds.

Exclusion criteria

  • Non-dermatology or non-photobiology specialists without relevant experience.

Less than 5 years of relevant clinical or research experience.

Limited or no experience with photoprotection counseling or research.

Significant undisclosed conflict of interest related to sunscreen or photoprotection products.

Inability or unwillingness to participate in all Delphi rounds.

Trial design

15 participants in 1 patient group

Expert Panel
Description:
The study population will consist of a purposive sample of dermatologists, photobiologists, and other experts actively involved in photoprotection research, clinical practice, or public health initiatives. Panelists should have experience advising patients or the public on sunscreen use, UV protection strategies, or photodermatoses. Panel Size and Rationale: Target enrollment: 20-35 experts Large enough to capture diverse perspectives while remaining feasible for iterative Delphi rounds. Minimum for analysis: 15 panelists to ensure adequate representativeness in case of attrition.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems